Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Trend
Above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
0.00%
↑ 100% above average
Average (26q)
-72.23%
Historical baseline
Range
High:116.28%
Low:-1082.11%
Volatility
-1659.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 44.78% |
| Q1 2025 | 0.00% |
| Q4 2024 | -19.64% |
| Q3 2024 | 54.84% |
| Q2 2024 | -985.71% |
| Q1 2024 | 116.28% |
| Q4 2023 | -8.86% |
| Q3 2023 | 57.30% |
| Q2 2023 | -79.61% |
| Q1 2023 | -27.16% |
| Q4 2022 | 11.96% |
| Q3 2022 | 25.20% |
| Q2 2022 | 3.15% |
| Q1 2022 | -14.41% |
| Q4 2021 | -1082.11% |
| Q3 2021 | 92.99% |
| Q2 2021 | -8.06% |
| Q1 2021 | -22.77% |
| Q4 2020 | -10.99% |
| Q3 2020 | -16.67% |
| Q2 2020 | -65.96% |
| Q1 2020 | -6.82% |
| Q4 2019 | 35.29% |
| Q3 2019 | -17.24% |
| Q2 2019 | -26.09% |
| Q1 2019 | 0.00% |